Doyle Wealth Management’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
Doyle Wealth Management's NVS Position: Q3 2019 in Review
Doyle Wealth Management sold out of Novartis (NVS) in Q3 2019, closing a stake of 1,739 shares — an estimated $159K sold.
Doyle Wealth Management first reported a position in NVS in Q4 2018 and held it in 2 quarters. The position peaked at $159K in Q2 2019. 1,090 funds tracked by Wall St. Rank hold NVS as of Q3 2019.
- Doyle Wealth Management reported no remaining Novartis position as of Q3 2019 after selling out during the quarter.
- Doyle Wealth Management sold 1,739 Novartis shares in Q3 2019, an estimated $159K.
- Doyle Wealth Management first reported a position in Novartis in Q4 2018 and held it in 2 quarters.
- Doyle Wealth Management's Novartis position peaked at $159K in Q2 2019.
- 1,090 funds tracked by Wall St. Rank held Novartis as of Q3 2019.
Based on Doyle Wealth Management's 13F filing for Q3 2019, filed 5 Nov 2019.